Identifying Factors to Predict Benefit from Bevacizumab in Progressive Glioblastoma Multiforme (GBM).Jack Patrick Gleeson,Abdullah Alhusaini,Philip O'Halloran,Emily Harrold,Niamh M. Keegan, Nabeeha Eltag Karadawi,Emin Mammadov,Dalia Kamel,Keith Egan, Susan Molloy,Bryan T. Hennessy,Oscar S. Breathnach,William Grogan,Patrick G. MorrisJOURNAL OF CLINICAL ONCOLOGY（2017）引用 0|浏览32AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
